Mitochondrial bioenergetic deficits in the hippocampi of rats with chronic ischemia-induced vascular dementia

Neuroscience

Volumn 231, Issue , 2013, Pages 345-352

  Du, J ^a   Ma, M ^a   Zhao, Q ^a   Fang, L ^b   Chang, J ^a   Wang, Y ^a   Fei, R ^a   Song, X ^a  

^a JILIN UNIVERSITY   (China)

^b Department of Neurology   (China)

Author keywords

Bioenergetic deficit; Mitochondria; Vascular dementia

Indexed keywords

CYTOCHROME C OXIDASE; HYDROGEN PEROXIDE; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE A1; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; CAROTID ARTERY OBSTRUCTION; COMMON CAROTID ARTERY; CONTROLLED STUDY; FUNCTIONAL ASSESSMENT; HIPPOCAMPUS; MALE; MAZE TEST; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL RESPIRATION; MULTIINFARCT DEMENTIA; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN ISCHEMIA; DEMENTIA, VASCULAR; ELECTRON TRANSPORT COMPLEX IV; ENERGY METABOLISM; HIPPOCAMPUS; HYDROGEN PEROXIDE; MALE; MAZE LEARNING; MITOCHONDRIA; NEURONS; OXIDATIVE STRESS; PYRUVATE DEHYDROGENASE COMPLEX; RATS; RATS, WISTAR;

EID: 84872376406     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.11.062     Document Type: Article

References (39)

1. Acuña-Castroviejo D., Martín M., Macías M., Escames G., León J., Khaldy H., Reiter R.J. Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res 2001, 30:65-74.
2. Bandyopadhyay U., Das D., Banerjee R.K. Reactive oxygen species: oxidative damage and pathogenesis. Curr Sci 1999, 77:658-666.
3. Cechetti F., Worm P.V., Pereira L.O., Siqueira I.R., Netto C.A. The modified 2VO ischemia protocol causes cognitive impairment similar to that induced by the standard method, but with a better survival rate. Braz J Med Biol Res 2010, 43:1178-1183.
4. Chan D.C. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006, 125:1241-1252.
5. de la Torre J.C. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004, 3:184-190.
6. Diepart C., Verrax J., Calderon P.B., Feron O., Jordan B.F., Gallez B. Comparison of methods for measuring oxygen consumption in tumor cells in vitro. Anal Biochem 2010, 396:250-256.
7. Dodson M.W., Guo M. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. Curr Opin Neurobiol 2007, 17:331-337.
8. Dong M.J., Peng B., Lin X.T., Zhao J., Zhou Yr, Wang R.H. The prevalence of dementia in the People's Republic of China: a systematic analysis of 1980-2004 studies. Age Ageing 2007, 36:619-624.
9. Guevara R., Santandreu F.M., Valle A., Gianotti M., Oliver J., Roca P. Sex-dependent differences in aged rat brain mitochondrial function and oxidative stress. Free Radical Biol Med 2009, 46:169-175.
10. Halim N.D., Mcfate T., Mohyeldin A., Okagaki P., Korotchkina L.G., Patel M.S., Jeoung N.H., Harris R.A., Schell M.J., Verma A. Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neurons. Glia 2010, 58:1168-1176.
11. Han D., Tian Y., Zhang T., Ren G., Yang Z. Nano- zinc oxide damages spatial cognition capability via over-enhanced long-term potentiation in hippocampus of Wistar rats. Int J Nanomed 2011, 6:1453-1461.
12. Hill J., Fillit H., Shah S.N., Valle M.C., Futterman R. Patterns of healthcare utilization and costs for vascular dementia in a community-dwelling population. J Alzheimer Dis 2005, 8:43-50.
13. Horecky J., Baciak L., Kasparova S., Pacheco G., Aliev G., Vancova O. Minimally invasive surgical approach for three-vessel occlusion as a model of vascular dementia in the rat-brain bioenergetics assay. Neurol Sci 2009, 283:178-181.
14. Hynes J., Hill R., Dmitri B. The use of a fluorescence-based oxygen uptake assay in the analysis of cytotoxicity. Toxicol In Vitro 2006, 20:785-792.
15. Hynes J., Marroquin L.D., Ogurtsov V.I., Christiansen K.N., Stevens G.J., Papkovsky D.B., Will Y. Investigation of drug-induced mitochondrial toxicity using fluorescence-based oxygen-sensitive probes. Toxicol Sci 2006, 92:186-200.
16. Irwin R.W., Yao J., Hamilton R.T., Cadenas E., Brinton R.D., Nilsen J. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 2008, 149:3167-3175.
17. Jing L., Kumari S., Mendelev N., Li P.A. Coenzyme Q10 ameliorates ultraviolet B irradiation induced cell death through inhibition of mitochondrial intrinsic cell death pathway. Int J Mol Sci 2011, 12:8302-8315.
18. Johannsen D.L., Ravussin E. The role of mitochondria in health and disease. Curr Opin Pharmacol 2009, 9:780-786.
19. Jones T.T., Brewer G.J. Age-related deficiencies in complex I endogenous substrate availability and reserve capacity of complex IV in cortical neuron electron transport. Biochim Biophys Acta 2010, 1797:167-176.
20. Kalaria R.N., Maestre G.E., Arizaga R., Friedland R.P., Galasko D., Hall K., Luchsinger J.A., Ogunniyi A., Perry E.K., Potocnik F., Prince M., Stewart R., Wimo A., Zhang Z.X., Antuono P. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 2008, 7:812-826.
21. Kim S.K., Cho K.O., Kim S.Y. White matter damage and hippocampal neuro-degeneration induced by permanent bilateral occlusion of common carotid artery in the rat: comparison between Wistar and Sprague-Dawley strain. Korean J Physiol Pharmacol 2008, 12:89-94.
22. Kumar R.S., Narayanan S.N., Nayak S. Ascorbic acid protects against restraint stress-induced memory deficits in Wistar rats. Clinics 2009, 64:1211-1217.
23. Lee A.Y. Vascular Dementia. Chonnam Med J 2011, 47:66-71.
24. McVeigh C., Passmore P. Vascular dementia: prevention and treatment. Clin Interv Aging 2006, 1:229-235.
25. Moretti R., Torre P., Antonello R.M., Vilotti C., Pizzolato G. New treatment options for vascular dementia. Aging Health 2007, 3:209-222.
26. Nadanaciva S., Dykens J.A., Bernal A., Capaldi R.A., Will Y. Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration. Toxicol Appl Pharmacol 2007, 223:277-287.
27. Nemeria N., Yan Y., Zhang Z., Brown A.M., Arjunan P., Furey W., Guest J.R., Jordan F. Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by thiamin 2-thiazolone and thiamin 2-thiothiazolone diphosphates. Evidence for reversible tight-binding inhibition. J Biol Chem 2001, 276:45969-45978.
28. Neumann C.A., Krause D.S., Carman C.V., Das S., Dubey D.P., Abraham J.L., Bronson R.T., Fujiwara Y., Orkin S.H., Van Etten R.A. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 2003, 424:561-565.
29. Parle M, Bansal N (2011) Antiamnesic activity of an ayurvedic formulation chyawanprash in mice. Evid Based Complement Altern Med.
30. Pecinová A., Drahota Z., Nůsková H., Pecina P., HouŠtěk J. Evaluation of basic mitochondrial functions using rat tissue homogenates. Mitochondrion 2011, 11:722-728.
31. Peng Y., Xu S.F., Chen G.Q., Wang L., Feng Y.P., Wang X.L. l-3-n-Butylphthalide improves cognitive impairment induced by chronic cerebral hypoperfusion in rats. J Pharmacol Exp Ther 2007, 321:902-910.
32. Pennisi G., Ferri R., Cantone M., Lanza G., Pennisi M., Vinciguerra L., Malaguarnera G., Bella R. A review of transcranial magnetic stimulation in vascular dementia. Dement Geriatr Cogn Disord 2011, 31:71-80.
33. Román G. Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci 2002, 203-204:7-10.
34. Sas K., Robotka H., Toldi J., Vécsei L. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 2007, 257:221-239.
35. Trushina E., McMurray C.T. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 2007, 145:1233-1248.
36. Wang X.D. The expanding role of mitochondria in apoptosis. Genes Dev 2001, 15:2922-2933.
37. Yamagishi S., Nakamura K., Matsui T. Role of oxidative stress in the development of vascular injury and its therapeutic intervention by nifedipine. Curr Med Chem 2008, 15:172-177.
38. Zhang X.D., Wang Y., Wang Y., Zhang X., Han R., Wu J.C., Liang Z.Q., Gu Z.L., Han F., Fukunaga K., Qin Z.H. P53 mediates mitochondria dysfunction-triggered autophagy activation and cell death in rat striatum. Autophagy 2009, 5:339-350.
39. Zhao Q., Zhang Y.L., Zhao M.M., Wang Y., Ma M., Gu X.Q., Cao X. Hippocampal mitochondrial cytochrome C oxidase activity and gene expression in a rat model of chronic cerebral ischemia. Neural Regen Res 2011, 32:2527-2531.